Summary
The abilities of various 5-hydroxytryptamine (5 HT) receptor agonists to inhibit the K+-evoked release of 3H-5 HT from prelabelled synaptosomal preparations of rat hypothalamus were studied. In addition, the abilities of various 5 HT receptor agonists and antagonists to compete with 3H-5 HT and 3H-spiperone binding to 5 HT1 and 5 HT2 sites, respectively, were determined. The orders of potency of the agonists for inhibiting K+-evoked 3H-5 HT release and for inhibiting 3H-5 HT and 3H-spiperone binding were then compared. Likewise, the abilities of the antagonists to block the inhibitory effect of 5 HT on its own K+-evoked release (data from previous studies) were compared to the affinities of these compounds for the 3H-5 HT and 3H-spiperone binding sites.
A significant correlation was obtained between the effects of the agonists on K+-evoked 3H-5 HT release and 3H-5 HT binding but not 3H-spiperone binding. Furthermore, the antagonists which have been demonstrated to block the inhibitory effect of 5 HT on its own release (methiothepin, methysergide, metergoline and quipazine) had higher affinities for the 3H-5 HT binding site than the other antagonists. A similar correlation could not be made between antagonist activity at the 5 HT autoreceptor and affinity for the 3H-spiperone binding site.
These results demonstrate that the 5 HT autoreceptor and the 5 HT1 binding site have similar pharmacological characteristics. On this basis, it is suggested that 5 HT autoreceptor and the 5 HT1 binding site may be related 5 HT receptor sites.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bennett JP, Snyder SH (1976) Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol Pharmacol 12:373–389
Blackshear MA, Sanders-Bush E (1982) Adaptive changes in serotonin receptors after chronic treatment with mianserin. J Pharmacol Exp ther 221:303–308
Blackshear MA, Steranka, LR, Sanders-Bush E (1981) Multiple serotonin receptors: regional distribution and effect of raphe lesions. Eur J Pharmacol 76:325–334
Cerrito F, Raiteri M (1979) Serotonin release is modulated by presynaptic autoreceptors. Eur J Pharmacol 57:427–430
de Montigny C, Aghajanian GK (1977) Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: a comparative iontophoretic study with LSD and serotonin. Neuropharmacology 16:811–818
Ennis C (1981) 5-Hydroxytryptamine receptors in the raphe nucleus of the rat. Br J Pharmacol 74:290P
Ennis C, Kemp JD, Cox B (1981) Characterization of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J Neurochem 36:1515–1520
Fillion G, Beaudoin D, Rousselle JC, Deniau JM, Fillion MP, Dray F, Jacob J (1979) Decrease of [3H]-5HT high affinity binding and 5 HT adenylate cyclase activation after kainic acid lesion in the rat brain striatum. J Neurochem 33:567–570
Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. I. The disposition of [5H]-norepinephrine, [3H-dopamine and [3H]-dopa in various regions of the brain. J Neurochem 13:665–669
Gothert M (1980) Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurons of the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 314:223–230
Gothert M, Weinheimer GL (1979) Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 310:93–96
Haigler HI, Aghajanian GK (1977) Serotonin receptors in the brain. Fed Proc 36:2159–2164
Howlett DR, Nahorski SR (1980) Quantitative assessment of heterogenous 3H-spiperone binding to rat neostriatum and frontal cortex. Life Sci 26:511–517
Jacobowitz PM, Richardson JS (1978) Method for the rapid determination of norepinephrine, dopamine and serotonin in the same brain region. Pharmacol Biochem Behav 8:515–519
Martin LL, Sanders-Bush E (1982) The serotonin autoreceptor: antagonism by quipazine. Neuropharmacology 21:445–450
Nelson DL, Herbet A, Bourgoin S, Glowinski J, Hamon M (1978) Characteristics of central 5 HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol 14:983–995
Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]-5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36:220–226
Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: differential binding of [3H]-5-hydroxytryptamine, [3H]-lysergic acid diethylamide and [3H]-spiroperidol Mol Pharmacol 16:687–699
Raiteri M, Angelini F, Levi G (1974) A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 25:411–414
Schlicker E, Gothert M (1981) Antagonistic properties of quipazine at presynaptic serotonin receptors and α-adrenoceptors in rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 317:204–208
Whittaker VP, Michaelson IA, Kirkland RJA (1964) The separation of synaptic vesicles from nerve-ending particles (synaptosomes). Biochem J 90:293–303
Author information
Authors and Affiliations
Additional information
These investigations were supported by U.S. Public Health Service Grant MH-34007, Training Grant MH-15452 and the Tennessee Department of Mental Health and Retardation
Rights and permissions
About this article
Cite this article
Martin, L.L., Sanders-Bush, E. Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn-Schmiedeberg's Arch. Pharmacol. 321, 165–170 (1982). https://doi.org/10.1007/BF00505480
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00505480